Lucid Diagnostics Basic Shares Outstanding 2021-2024 | LUCD
Lucid Diagnostics basic shares outstanding from 2021 to 2024. Basic shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares.
| Lucid Diagnostics Annual Basic Shares Outstanding (Millions of US $) |
|
|---|---|
| 2024 | $51 |
| 2023 | $42 |
| 2022 | $36 |
| 2021 | $19 |
| 2020 | $14 |
| Lucid Diagnostics Quarterly Basic Shares Outstanding (Millions of US $) |
|
|---|---|
| 2024-12-31 | $51 |
| 2024-09-30 | $50 |
| 2024-06-30 | $48 |
| 2024-03-31 | $45 |
| 2023-12-31 | $42 |
| 2023-09-30 | $42 |
| 2023-06-30 | $42 |
| 2023-03-31 | $41 |
| 2022-12-31 | $36 |
| 2022-09-30 | $36 |
| 2022-06-30 | $36 |
| 2022-03-31 | $35 |
| 2021-12-31 | $19 |
| 2021-09-30 | $14 |
| 2021-06-30 | $14 |
| 2021-03-31 | $14 |
| 2020-12-31 | |
| 2020-09-30 | $14 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.135B | $0.004B |
| Lucid Diagnostics Inc. is a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. Lucid Diagnostics Inc. is based in NEW YORK. | |||